Abstract
A prospective, consecutive study of the aetiology of treatment-associated diarrhoea was conducted in 25 patients with disseminated germ cell cancer treated with intensive chemotherapy. Clostridium difficile was isolated in 45% of the diarrhoea episodes, which makes this species the most important bacterial pathogen in the development of clinically significant diarrhoea in this group of immunocompromised patients.
| Original language | English |
|---|---|
| Journal | British Journal of Cancer |
| Volume | 66 |
| Issue number | 4 |
| Pages (from-to) | 666-7 |
| Number of pages | 2 |
| ISSN | 0007-0920 |
| DOIs | |
| Publication status | Published - Oct 1992 |
| Externally published | Yes |
Keywords
- Antineoplastic Combined Chemotherapy Protocols/administration & dosage
- Bleomycin/administration & dosage
- Cisplatin/administration & dosage
- Clostridioides difficile/isolation & purification
- Diarrhea/drug therapy
- Etoposide/administration & dosage
- Humans
- Immunocompromised Host
- Neoplasms, Germ Cell and Embryonal/drug therapy
- Prevalence
- Prospective Studies
Fingerprint
Dive into the research topics of 'High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS